SG

Shailesh Ganpatrao Wagh

Active Director Director DIN 11464554
DIN 11464554 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shailesh Ganpatrao Wagh

Data last updated:

Shailesh Ganpatrao Wagh is a Director at Neurogliese Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11464554
Primary Designation Director
Industry Pharma
First Appointment 05 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jan 20262026Active

Board colleagues of Shailesh Ganpatrao Wagh

Directorship timeline

Open interactive timeline →
Neurogliese Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shailesh Ganpatrao Wagh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shailesh Ganpatrao Wagh

Shailesh Ganpatrao Wagh currently holds 1 directorship: Neurogliese Pharmaceuticals Private Limited (Director, since 05 Jan 2026).

Shailesh Ganpatrao Wagh was first appointed on 05 Jan 2026 as Director at Neurogliese Pharmaceuticals Private Limited.

The current boards of Shailesh Ganpatrao Wagh's companies include Nilesh Ganpatrao Wagh (Neurogliese Pharmaceuticals Private Limited), Rupesh Ganpatrao Wagh (Neurogliese Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available